Role of PCGEM1 in Breast Cancer
NCT: NCT07562789 · NOT_YET_RECRUITING
NCT IDNCT07562789
StatusNOT_YET_RECRUITING
Start Date2026-05-05
Completion2026-08-06
Brief Summary
This study examines certain molecular markers in breast cancer using blood and tissue samples from routine diagnostic biopsies. No extra procedures will be performed on patients. The goal is to improve understanding of disease mechanisms and identify potential targets for treatment
Frequently Asked Questions
What is Role of PCGEM1 in Breast Cancer?
Role of PCGEM1 in Breast Cancer is a clinical trial registered under NCT07562789. Current status: NOT_YET_RECRUITING.
What is the status of NCT07562789?
The current status of NCT07562789 (Role of PCGEM1 in Breast Cancer) is: NOT_YET_RECRUITING.
When did Role of PCGEM1 in Breast Cancer start?
Role of PCGEM1 in Breast Cancer started on 2026-05-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.